AGES:LSE:LSE-iShares IV Public Limited Company - iShares Ageing Population UCITS ETF (GBX)

ETF | Others |

Last Closing

USD 567.75

Change

0.00 (0.00)%

Market Cap

USD 0.46B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-23 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+3.46 (+1.26%)

USD 292,109.69B
XMTD:LSE Xtrackers MSCI Taiwan UCITS ET..

+0.55 (+0.82%)

USD 292,109.19B
0R1O:LSE Amazon.com Inc.

+8.00 (+4.26%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+0.33 (+0.27%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.04 (+0.26%)

USD 553.83B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.07 (+0.40%)

USD 553.83B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

+1.25 (+0.06%)

USD 321.87B
0QZK:LSE Coca-Cola Co.

-0.05 (-0.08%)

USD 266.08B
0QZO:LSE 0QZO

+0.20 (+0.20%)

USD 258.54B

ETFs Containing AGES:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.51% 48% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.51% 47% F 52% F
Trailing 12 Months  
Capital Gain 9.42% 46% F 53% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.42% 44% F 53% F
Trailing 5 Years  
Capital Gain 25.30% 50% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.30% 47% F 58% F
Average Annual (5 Year Horizon)  
Capital Gain 5.37% 53% F 59% D-
Dividend Return 5.37% 53% F 58% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.27% 55% F 70% C-
Risk Adjusted Return 40.48% 57% F 70% C-
Market Capitalization 0.46B 69% C- 52% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike